We are live on ! Find out more
HAE icon

Haemonetics
HAE

294 hedge funds and large institutions have $3.9B invested in Haemonetics in 2022 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 103 increasing their positions, 104 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

145% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 20

9% more funds holding

Funds holding: 270 → 294 (+24)

2% more capital invested

Capital invested by funds: $3.83B → $3.9B (+$73.2M)

1% less repeat investments, than reductions

Existing positions increased: 103 | Existing positions reduced: 104

1.32% less ownership

Funds ownership: 100.85% → 99.53% (-1.3%)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

56% less call options, than puts

Call options by funds: $3.35M | Put options by funds: $7.67M

Holders
294
Holders Change
+24
Holders Change %
+8.89%
% of All Funds
4.73%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
49
Increased
103
Reduced
104
Closed
20
Calls
$3.35M
Puts
$7.67M
Net Calls
-$4.32M
Net Calls Change
-$3.84M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$48.3M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$36.5M
3
BlackRock
BlackRock
New York
+$26.9M
4
Boston Partners
Boston Partners
Massachusetts
+$17.4M
5
Goldman Sachs
Goldman Sachs
New York
+$8.7M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$107M
2
LCP
LGT Capital Partners
Switzerland
-$38.1M
3
Capital Research Global Investors
Capital Research Global Investors
California
-$26.5M
4
Millennium Management
Millennium Management
New York
-$25.2M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$18M
Name Holding Trade Value Shares
Change 		Change in
Stake
Allspring Global Investments
26
Allspring Global Investments
North Carolina
$25.1M -$1.91M -23,750 -7%
Two Sigma Advisers
27
Two Sigma Advisers
New York
$24.1M -$3.22M -40,000 -12%
ACB
28
Aristotle Capital Boston
Massachusetts
$23.4M -$621K -7,721 -3%
LCP
29
LGT Capital Partners
Switzerland
$23.4M -$38.1M -473,510 -61%
Deutsche Bank
30
Deutsche Bank
Germany
$23.1M +$372K +4,628 +2%
Goldman Sachs
31
Goldman Sachs
New York
$19.6M +$8.7M +108,252 +77%
Victory Capital Management
32
Victory Capital Management
Texas
$19.3M -$4.47M -55,647 -18%
Jacobs Levy Equity Management
33
Jacobs Levy Equity Management
New Jersey
$19.1M -$778K -9,682 -4%
Morgan Stanley
34
Morgan Stanley
New York
$18.9M -$9.27M -115,360 -32%
Principal Financial Group
35
Principal Financial Group
Iowa
$16.4M -$367K -4,566 -2%
Royal Bank of Canada
36
Royal Bank of Canada
Ontario, Canada
$16.3M +$2.62M +32,574 +19%
PAM
37
Panagora Asset Management
Massachusetts
$15.6M +$155K +1,933 +1%
N
38
Nuveen
North Carolina
$15.3M +$294K +3,655 +2%
SIC
39
Schwartz Investment Counsel
Michigan
$14.5M – – –
Retirement Systems of Alabama
40
Retirement Systems of Alabama
Alabama
$14.3M -$38.7K -481 -0.3%
EA
41
Emerald Advisers
Pennsylvania
$13.9M -$11.7M -145,097 -45%
Assenagon Asset Management
42
Assenagon Asset Management
Luxembourg
$13.5M -$47.8K -595 -0.3%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$12.9M -$72.7K -905 -0.6%
LCOV
44
London Company of Virginia
Virginia
$12.2M -$525K -6,529 -4%
JP Morgan Chase
45
JP Morgan Chase
New York
$12M +$543K +6,752 +5%
CSS
46
Cubist Systematic Strategies
Connecticut
$11.8M +$7M +87,102 +138%
Citigroup
47
Citigroup
New York
$11.5M +$3.87M +48,101 +49%
EMFAT
48
Emerald Mutual Fund Advisers Trust
Pennsylvania
$11M -$10.2M -126,841 -48%
PCM
49
Peregrine Capital Management
Minnesota
$10.5M -$1.37M -16,991 -11%
PHP
50
Parkman Healthcare Partners
Connecticut
$10.4M +$1.33M +16,581 +14%
1
2
3 4 5

HAE Hedge Fund Activity: Q4 2022 in Review

294 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q4 2022, worth a combined $3.9B — up 1.9% from $3.83B a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new HAE positions and 20 closed out — a net gain of 29 holders — while 103 added to existing stakes and 104 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $48.3M. The largest seller was Wellington Management Group, cutting an estimated $107M.

  • 294 institutional investors held Haemonetics (HAE) as of Q4 2022, up from 270 in Q3 2022.
  • Funds reported $3.9B of Haemonetics stock for Q4 2022, up 1.9% quarter-over-quarter.
  • 49 funds opened new Haemonetics positions in Q4 2022 and 20 closed out, a net change of +29 holders.
  • The largest Haemonetics buyer in Q4 2022 was Fidelity Investments, an estimated $48.3M added.
  • The largest Haemonetics seller in Q4 2022 was Wellington Management Group, an estimated $107M sold.

Based on aggregated 13F filings for Q4 2022.